Diabetes

The Pharmacy Times® Diabetes resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
[[thumbnail_alt_text]]
Proper Safety Measures to Protect Pharmacy Staff During COVID-19 Outbreak
Key best practices for protecting pharmacy personnel during the COVID-19 pandemic.
[[thumbnail_alt_text]]
CMS Approves More Medicaid Section 1135 Waivers, Bringing Total to 34 States
The waivers were approved within days of the states' submissions.
[[thumbnail_alt_text]]
Pharmacist in Action: COVID-19 Preparedness
Curtis E. Haas, PharmD, FCCP, editor-in-chief of Pharmacy Times: Directions in Health-System Pharmacy, and chief pharmacy officer for the University of Rochester’s health care system, discusses preparation for potential patient surge due to COVID-19.
[[thumbnail_alt_text]]
Pharmacy Hero: Technician Spends Free Time Making, Distributing Masks to Protect Against COVID-19
Today’s pharmacy hero is Diane Berkley, CPhT. In addition to working full time at a local hospital during the day, Berkley also works part-time at a community pharmacy.
 
[[thumbnail_alt_text]]
FDA Releases Statement on Increase of US Supply of Ventilators, Respirators for Health Care
The FDA has issued a statement regarding action to help increase the supply of ventilators, ventilator tubing connectors, and ventilator accessories during the COVID-19 pandemic.
[[thumbnail_alt_text]]
Week in Review: Pharmacies Step Up COVID-19 Safety Measures
Top news of the week from Pharmacy Times® surrounding the novel coronavirus.
[[thumbnail_alt_text]]
FDA Issues Complete Response Letter on Adjunct Therapy for Patients With Type 1 Diabetes
The FDA has issued a complete response letter for the supplemental New Drug Application of the investigational medicine empagliflozin 2.5 mg as an adjunct to insulin for adults with type 1 diabetes.
 
[[thumbnail_alt_text]]
Emergency Use Authorizations Increase for COVID-19 Tests
The EUA designation allows the test to be used to detect SARS-CoV-2, the virus that causes COVID-19, for the duration of the continuing pandemic.
[[thumbnail_alt_text]]
COVID-19: An Overview of Reported, Investigational Pharmaceutical Treatments
Many front-line clinicians have been investigating existing medications and repurposing them for COVID-19 treatment.
[[thumbnail_alt_text]]
Camber Pharma Launches Generic Lyrica® Capsules
Pregabalin capsules is used to treat pain caused by nerve damage due to diabetes or shingles infection. 
[[thumbnail_alt_text]]
Vaccine in Development for Coronavirus Disease 2019
Hoth Therapeutics and Voltron Therapeutics will collaborate to develop the self-assembling vaccine technology as a means to aid patients at risk of being infected with COVID-19.
[[thumbnail_alt_text]]
Standard Insulin Pen Needles Require Caution
Mandatory, scripted patient education and device demonstrations are vital to avoid harm.

The Pharmacy Times® Diabetes specialty page serves as a hub for all clinical news and articles related to the condition. The coverage includes best practices for treating diabetes, from the early signs and symptoms like increased thirst, fatigue, and blurred vision; and addresses the primary causes of diabetes – the destruction of insulin-producing beta cells of the pancreas.

The Pharmacy Times® Diabetes condition center provides a source of all the latest clinical information, with articles covering updates from the robust pipeline of novel diabetes therapies, and the newest data from all phases of clinical trials and studies in the space.